Cargando…

Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis

BACKGROUND: Brain metastasis occurs in 1–2.5% of epithelial ovarian cancer (EOC) cases and carries a poor prognosis. Typically, brain metastases arise 2–3 years following the primary diagnosis of EOC. Malignant spread to the brain discovered at the time of initial ovarian cancer presentation is exce...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahn, Ryan Matthew, Gandhi, Shreena Kamlesh, Mvula, Mwamba Rebecca, Li, Xuan, Frey, Melissa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508680/
https://www.ncbi.nlm.nih.gov/pubmed/32995454
http://dx.doi.org/10.1016/j.gore.2020.100641
_version_ 1783585461312159744
author Kahn, Ryan Matthew
Gandhi, Shreena Kamlesh
Mvula, Mwamba Rebecca
Li, Xuan
Frey, Melissa K.
author_facet Kahn, Ryan Matthew
Gandhi, Shreena Kamlesh
Mvula, Mwamba Rebecca
Li, Xuan
Frey, Melissa K.
author_sort Kahn, Ryan Matthew
collection PubMed
description BACKGROUND: Brain metastasis occurs in 1–2.5% of epithelial ovarian cancer (EOC) cases and carries a poor prognosis. Typically, brain metastases arise 2–3 years following the primary diagnosis of EOC. Malignant spread to the brain discovered at the time of initial ovarian cancer presentation is exceedingly rare with minimal reported cases in literature. CASE: This is a rare case of highly aggressive EOC in a previously healthy 32-year-old woman with evidence of brain, bone, and vertebral metastasis at the time of initial diagnosis. This is the first reported case of EOC with spread to Meckel’s cave with symptoms consistent with trigeminal nerve disruption. The disease rapidly progressed through radiation and front-line chemotherapy. CONCLUSION: This report highlights the first reported case of EOC with invasion of Meckel’s cave—present at time of diagnosis. Consistent with most cases in the literature of brain metastasis in the setting of EOC, our patient had a highly aggressive tumor associated with a poor prognosis. With better primary management of EOC, along with increased overall survival in EOC patients following spread to the brain secondary to multimodal therapies, we can continue to expect increasing numbers of brain metastasis with uncommon sites of recurrence.
format Online
Article
Text
id pubmed-7508680
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75086802020-09-28 Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis Kahn, Ryan Matthew Gandhi, Shreena Kamlesh Mvula, Mwamba Rebecca Li, Xuan Frey, Melissa K. Gynecol Oncol Rep Case Report BACKGROUND: Brain metastasis occurs in 1–2.5% of epithelial ovarian cancer (EOC) cases and carries a poor prognosis. Typically, brain metastases arise 2–3 years following the primary diagnosis of EOC. Malignant spread to the brain discovered at the time of initial ovarian cancer presentation is exceedingly rare with minimal reported cases in literature. CASE: This is a rare case of highly aggressive EOC in a previously healthy 32-year-old woman with evidence of brain, bone, and vertebral metastasis at the time of initial diagnosis. This is the first reported case of EOC with spread to Meckel’s cave with symptoms consistent with trigeminal nerve disruption. The disease rapidly progressed through radiation and front-line chemotherapy. CONCLUSION: This report highlights the first reported case of EOC with invasion of Meckel’s cave—present at time of diagnosis. Consistent with most cases in the literature of brain metastasis in the setting of EOC, our patient had a highly aggressive tumor associated with a poor prognosis. With better primary management of EOC, along with increased overall survival in EOC patients following spread to the brain secondary to multimodal therapies, we can continue to expect increasing numbers of brain metastasis with uncommon sites of recurrence. Elsevier 2020-09-11 /pmc/articles/PMC7508680/ /pubmed/32995454 http://dx.doi.org/10.1016/j.gore.2020.100641 Text en © 2020 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Kahn, Ryan Matthew
Gandhi, Shreena Kamlesh
Mvula, Mwamba Rebecca
Li, Xuan
Frey, Melissa K.
Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis
title Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis
title_full Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis
title_fullStr Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis
title_full_unstemmed Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis
title_short Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis
title_sort metastatic epithelial ovarian cancer to meckel’s cave with leptomeningeal spread at time of diagnosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508680/
https://www.ncbi.nlm.nih.gov/pubmed/32995454
http://dx.doi.org/10.1016/j.gore.2020.100641
work_keys_str_mv AT kahnryanmatthew metastaticepithelialovariancancertomeckelscavewithleptomeningealspreadattimeofdiagnosis
AT gandhishreenakamlesh metastaticepithelialovariancancertomeckelscavewithleptomeningealspreadattimeofdiagnosis
AT mvulamwambarebecca metastaticepithelialovariancancertomeckelscavewithleptomeningealspreadattimeofdiagnosis
AT lixuan metastaticepithelialovariancancertomeckelscavewithleptomeningealspreadattimeofdiagnosis
AT freymelissak metastaticepithelialovariancancertomeckelscavewithleptomeningealspreadattimeofdiagnosis